Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19.
Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.
Elhouderi E, El Sawalhy E, Kabbani M. Myopericarditis after mRNA COVID-19 vaccine in a patient with recent history of COVID-19. Cureus. 2022 May 23;14(5):e25264. doi: 10.7759/cureus.25264. PMID: 35755512.